Funder
National Key Research and Development Program of China
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference55 articles.
1. Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., et al. (2016). 2016 ESC/EAS guidelines for the management of dyslipidaemias. The task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) developed with the special contribution of the European Association for cardiovascular prevention & rehabilitation (EACPR). Atherosclerosis,253, 281–344.
2. Jellinger, P. S., Handelsman, Y., Rosenblit, P. D., Bloomgarden, Z. T., Fonseca, V. A., Garber, A. J., et al. (2017). American association of clinical endocrinologists and American College of endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease—Executive summary. Endocrine Practice,23(4), 479–497.
3. Wang, Z., Wang, X., Hao, G., Chen, Z., Zhang, L., Shao, L., et al. (2019). A national study of the prevalence and risk factors associated with peripheral arterial disease from China: The China Hypertension Survey, 2012–2015. International Journal of Cardiology,275, 165–170.
4. de la Sierra, A., Pinto, X., Guijarro, C., Miranda, J. L., Callejo, D., Cuervo, J., et al. (2015). Prevalence, treatment, and control of hypercholesterolemia in high cardiovascular risk patients: Evidences from a systematic literature review in Spain. Advances in Therapy,32(10), 944–961.
5. Moran, A., Gu, D., Zhao, D., Coxson, P., Wang, Y. C., Chen, C. S., et al. (2010). Future cardiovascular disease in china: Markov model and risk factor scenario projections from the coronary heart disease policy model-china. Circulation,3(3), 243–252.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献